Bofanglutide for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medication called Bofanglutide (an injectable drug, similar to others in its class) to see if it can help control blood sugar in adults with type 2 diabetes. It may also help with weight management. Participants will continue taking their current diabetes medication (metformin).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with type 2 diabetes for more than 6 months.
- You are currently taking metformin at a stable dose of at least 1000 mg per day for at least 3 months.
- Your most recent A1C (average blood sugar over 3 months) is between 7.0% and 10.5%.
- Your body mass index (BMI) is 27 or higher.
- If you are female and able to have children, you must agree to use effective birth control during the study and for 6 months after the last dose.
- If you are male, you must not plan to donate sperm during the study and for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This trial tests a medicine called semaglutide (often used for diabetes) to see if it helps people in Bangladesh who are overweight or obese lose weight. The study will check if the medicine is safe and effective for both people with and without type 2 diabetes.
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
This study tests a new medication called PG-102 against a placebo and an existing medication (semaglutide) to see how well it controls blood sugar in people with type 2 diabetes. It may offer a new treatment option that could help lower your blood sugar levels.
This study tests an investigational pill for people with type 2 diabetes whose blood sugar is not well controlled despite lifestyle changes or metformin. The pill may help improve blood sugar control and is taken by mouth.
This study tests a new medication called semaglutide (similar to Ozempic) in people with type 2 diabetes who are already taking metformin. It aims to see if this medication improves blood sugar control and may also help with weight loss.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.